Guangzhou Kingmed Diagnostics Group Co Ltd
KingMed Diagnostics's GHG Emissions Data Preview
In 2023, KingMed Diagnostics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, KingMed Diagnostics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind KingMed Diagnostics’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore KingMed Diagnostics’s data sources below and access millions more through our Disclosure Search.
Insights into KingMed Diagnostics's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of KingMed Diagnostics amounted to 34,374.54 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of KingMed Diagnostics decreased by 6.51%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
KingMed Diagnostics's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are KingMed Diagnostics's Scope 1 emissions?
In 2023, the total Scope 1 emissions of KingMed Diagnostics were 5,235.95 metric tons of CO₂ equivalent (tCO₂e). a
Has KingMed Diagnostics reduced its Scope 1 emissions over time?
Since 2021, KingMed Diagnostics's Scope 1 emissions have decreased by 41.93%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), KingMed Diagnostics's Scope 1 emissions decreased by 30.49%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are KingMed Diagnostics's Scope 2 emissions?
In 2023, KingMed Diagnostics reported Scope 2 greenhouse gas (GHG) emissions of 29,138.59 tCO₂e using the location-based method. a
Has KingMed Diagnostics reduced its Scope 2 emissions over time?
Since 2021, KingMed Diagnostics's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have increased by 21.84%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2022), KingMed Diagnostics's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that KingMed Diagnostics 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does KingMed Diagnostics use for Scope 2 reporting?
In 2023, KingMed Diagnostics reported its Scope 2 emissions using the location-based method. a
KingMed Diagnostics's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
Insights into KingMed Diagnostics’s GHG Emissions Intensity Compared to Industry Peers
In 2023, KingMed Diagnostics reported Scope 1 greenhouse gas (GHG) emissions of 5,235.95 tCO₂e and total revenues of USD 1,202 millions. This translates into an emissions intensity of 4.36 tCO₂e per millions USD. a
KingMed Diagnostics's Scope 1 Emissions Intensity Compared to Peers
How does KingMed Diagnostics's GHG emissions intensity compare to its peers?
In 2023, KingMed Diagnostics reported a Scope 1 emissions intensity of 4.36 tCO₂e per millions USD. Compared to the peer group median of 7.84 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does KingMed Diagnostics rank on GHG emissions intensity within its industry?
In 2023, KingMed Diagnostics ranked 10 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
KingMed Diagnostics is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a